为什么永远不会有 NTRK 重排肿瘤的随机试验 ?
求助全文
关键词: Molecularly targeted therapies Randomized trial Ultra-rare cancers
Mesh : Humans Neoplasms / pathology Receptor, trkA / genetics Oncogene Proteins, Fusion
来 源: DOI:10.1016/j.annonc.2023.04.001